Результатов: 9068

Top Crypto Presales to Watch: Pepeto, OpenFundNet (OFNT), and FloppyPepe

The presale environment in 2025 is maturing fast. What used to be driven by pure speculation is now shaped by clear utility, emissions models, and real user incentives. With institutional players watching altcoins and Ethereum scaling through L2s, retail investors are pouring into presales that promise early access, transparent mechanics, and long-term value. дальше »

2025-7-22 21:30


LINK, SOL, and DOGE all see upgrades, but analysts say this coin could beat them all

The recent upgrades to Chainlink (LINK), Solana (SOL), and Dogecoin (DOGE) are reshaping their roles in the crypto ecosystem, each leveraging distinct technological advancements. Chainlink’s Cross-Chain Interoperability Protocol (CCIP) is gaining traction, enabling seamless data integration across blockchains, with institutional adoption driving LINK’s price toward a projected $32 in 2025. дальше »

2025-7-21 06:09


This $0.03 token could flip LINK; 3000% gains projected by Q4, presale 80% complete

With a current price of just $0.03 and a rising presale pace, it is quickly becoming the next high-growth opportunity retail and institutional investors are watching closely. A new DeFi economy in motion Mutuum Finance (MUTM) is setting itself apart in the DeFi space with a planned dual-track lending architecture designed to support a wide […] дальше »

2025-7-18 10:07


MicroStrategy’s Bitcoin blueprint goes mainstream: Wall Street now holds 6% BTC

Key Takeaways MicroStrategy’s aggressive accumulation has gone mainstream, setting the blueprint for institutional exposure to Bitcoin. Over 8% of the BTC supply is expected to be locked up by yearThe post MicroStrategy’s Bitcoin blueprint goes mainstream: Wall Street now holds 6% BTC appeared first on AMBCrypto. дальше »

2025-7-15 17:00


HYPE coin price up 200%, Sonnet BioTherapeutics merges into Hyperliquid Strategies

The cryptocurrency space has seen a wave of momentum around Hyperliquid, as its native token HYPE continues to surge in value and institutional attention reaches new heights. In a remarkable move that signals growing faith in digital assets, Nasdaq-listed Sonnet BioTherapeutics has announced a strategic merger and rebrand aimed at establishing one of the largest […] дальше »

2025-7-15 19:20